PRTN3 and rheumatoid arthritis: In the majority of patients with RA, circulating autoantibodies are detectable; the most represented are the rheumatoid factor (RF) and the antibodies to citrullinated protein antigens (ACPA) commonly identified by antibodies to cyclic citrullinated peptides (anti-CCP) [3, 4].